跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 47 条关于
“LGMDR9”
全部
47
临床试验
29
药物
7
机构
0
资讯
11
去年
Cure Rare Disease Advances LGMDR9 Gene Therapy Following Positive FDA Pre-IND Meeting
去年
AskBio's AB-1003 Receives FDA Designations for LGMD2I/R9 Treatment
去年
Sarepta Therapeutics Completes Dosing in Phase III Trial of SRP-9003 for LGMD2E/R4
去年
BridgeBio's BBP-418 Completes Enrollment in Phase 3 Trial for LGMD2I/R9
去年
FDA Clears Atamyo's ATA-200 Gene Therapy Trial for LGMD2C/R5 in Children
9个月前
Cure Rare Disease Secures $7.4 Million CIRM Grant for Novel Gene Therapy Targeting LGMD2i/R9
去年
AskBio's AB-1003 Receives FDA Rare Pediatric Disease and Orphan Drug Designations for LGMD2I/R9
去年
LGMD Therapeutics: Competitive Landscape and Pipeline Analysis
去年
Atamyo Therapeutics' ATA-200 Gene Therapy Receives FDA Clearance for US Clinical Trial in LGMD2C/R5
2年前
Atamyo Therapeutics Advances Gene Therapy Programs for Limb-Girdle Muscular Dystrophy
第 1 页,共 2 页
上一页
下一页